JLB & ASSOCIATES INC
Q2 2014 13F-HR Holdings
Net value change ($000)
+7,110
(2.6%)
New positions
0
Sold out positions
1
Turnover %
0.1%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2014
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Dr Pepper Snapple Group Inc | 1,694 | 151.3% |
| DLX | 1,631 | 88.3% |
| AAPL | 1,566 | 26.8% |
| GILD | 946 | 10.7% |
| CORE LABORATORIES N V | 790 | 27.4% |
| CNI | 756 | 31.7% |
| GPN | 709 | 65.8% |
| SEIC | 637 | 11.9% |
| PEP | 527 | 8.2% |
| GGG | 482 | 7.2% |
Top Reduces (Value $000, Stocks/ETFs)
| ABT | -1,581 | -68.9% |
| CSCO | -1,265 | -58.5% |
| COACH INC | -978 | -31.7% |
| ALTERA | -841 | -20.9% |
| ALLIANT TECHSYSTEMS INC | -472 | -6.7% |
| QUESTCOR PHARMACEUTICALS INC COM | -393 | -100.0% |
| TJX | -360 | -6.9% |
| PII | -358 | -5.1% |
| ROST | -353 | -6.4% |
| FLS | -343 | -26.8% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|